The M&A-focused Betaville blog sent an alert to its subscribers related to a rumor regarding Janux Therapeutics (JANX), contacts tell The Fly.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JANX:
- Janux Therapeutics Advances with Promising Study on JANX008 for Solid Tumor Treatment
- Janux Therapeutics Advances Prostate Cancer Study with JANX007
- BTIG biotech analyst holds an analyst/industry conference call
- Janux Therapeutics Announces Departure of Chief Strategy Officer
- Janux Therapeutics initiated with an Overweight at Barclays